Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
- PMID: 29379322
- PMCID: PMC5759851
- DOI: 10.2147/PROM.S144992
Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
Abstract
Objective: The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are multisystem diseases of the small blood vessels. Patients experience irreversible damage and psychological effects from AAV and its treatment. An international collaboration was created to investigate the impact of AAV on health-related quality of life (HRQoL), and develop a disease-specific patient-reported outcome measure to assess outcomes of importance to patients.
Methods: Patients with AAV from the UK, USA, and Canada were interviewed to identify salient aspects of HRQoL affected by AAV. The study was overseen by a steering committee including four patient research partners. Purposive sampling of interviewees ensured representation of a range of disease manifestations and demographics. Inductive analysis was used to identify themes of importance to patients; these were further confirmed by a free-listing exercise in the US. Individual themes were recast into candidate items, which were scrutinized by patients, piloted through cognitive interviews and received a linguistic and translatability evaluation.
Results: Fifty interviews, conducted to saturation, with patients from the UK, USA, and Canada, identified 55 individual themes of interest within seven broad domains: general health perceptions, impact on function, psychological perceptions, social perceptions, social contact, social role, and symptoms. Individual themes were constructed into >100 candidate questionnaire items, which were then reduced and refined to 35 candidate items.
Conclusion: This is the largest international qualitative analysis of HRQoL in AAV to date, and the results have underpinned the development of 35 candidate items for a disease-specific, patient-reported outcome questionnaire.
Keywords: ANCA-associated vasculitis; eosinophilic granulomatosis with polyangiitis; granuloma-tosis with polyangiitis; microscopic polyangiitis; patient-reported outcomes; quality of life.
Conflict of interest statement
Disclosure Dr Robson and Professor Luqmani were supported in part by the National Institute for Health Research Musculoskeletal Biomedical Research Unit, Oxford, UK. Dr Robson was supported by a National Institute for Health Research (NIHR) clinical lectureship. Dr Milman was supported by a UCB/Canadian Rheumatology Association/Arthritis Society postgraduate rheumatology fellowship award and a research fellowship from the Department of Medicine at the Ottawa Hospital. The authors report no other conflicts of interest in this work.
Figures
References
-
- Conway K, Patrick DL, Gauchon T, Acquadro C. Enhancing crosscultural appropriateness for newly developed patient-reported outcome (PRO) instruments: the use of translatability assessment. Patient Reported Outcomes Newsl. 2010;44:9–12.
-
- Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11. - PubMed
-
- McNicholas BA, Griffin TP, Donnellan S, et al. ANCA-associated vasculitis: a comparison of cases presenting to nephrology and rheumatology services. QJM. 2016;109(12):803–809. - PubMed
-
- Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75(9):1583–1594. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
